...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith BIO CEO & Investor Conference 2017 Slides

Good catch Fouremm. Yes, the enterprise value listed on today's slides ($500 MM) is twice that ($250 MM) listed back at the January 9 2017 Biotech showcase presentation and at the December 2016 annual meeting. And this is up from the June 2016 estimated enterprise value of $125 MM. 

Share
New Message
Please login to post a reply